The filing is routine and unlikely to move the stock. Traders should monitor for actual execution of the share buyback or capital reduction, which could provide modest EPS accretion. The renewed NASDAQ listing delegation keeps the potential for a U.S. listing alive but remains optional. The dividend payment on July 2 is a minor cash event.
GRFS drugs
GRFS drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 22 $7.28entry
- T+1 · 5mo ago −1.37%α +0.08% · $7.18
- T+5 · 5mo ago +1.51%α +3.58% · $7.39
- T+20 · 4mo ago −0.14%α +0.01% · $7.27
- T+60 · 2mo ago +1.10%α −0.65% · $7.36
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Grifols SA reported the results of its Ordinary General Shareholders' Meeting held on June 18, 2026. Shareholders approved the FY2025 annual accounts (profit of EUR 192,054 thousand), the distribution of an ordinary dividend of EUR 56,065,663 and a preferred dividend of EUR 2,614,251 for Class B shares, both payable July 2, 2026. The meeting also authorized a share capital reduction of up to 10% via treasury share redemption, renewed the delegation to list Class A shares on NASDAQ, and approved director re-elections and remuneration policy amendments. Item 11 (calling extraordinary meetings with 15 days' notice) failed to pass. This is a routine governance filing with no material new financial disclosures.
Key Facts
- FY2025 individual profit of EUR 192,054 thousand approved
- Ordinary dividend of EUR 56,065,663 and preferred dividend of EUR 2,614,251 declared, payable July 2, 2026
- Share capital reduction authorized up to 10% via redemption of treasury Class A and Class B shares
- Board authorized to increase share capital up to 50% over five years, with pre-emptive rights exclusion up to 20%
- Renewed delegation to list Class A shares on NASDAQ within three years
- Two independent directors re-elected for four-year terms
- Remuneration policy amended, raising maximum annual director compensation to EUR 3,500,000
- Item 11 (15-day notice for extraordinary meetings) not approved
Financial Impact
Dividend distribution of approximately EUR 58.7 million (ordinary + preferred), representing about 1.2% of market cap. Capital reduction and buyback authorizations are permissive, not executed.
Risk Factors
- Capital increase authorization could lead to dilution if exercised
- Share buyback and capital reduction are discretionary and may not occur
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001104659-26-075705 |
| Document: 0001104659-26-075705-index-headers.html | 0001104659-26-075705 |
| Document: 0001104659-26-075705-index.html | 0001104659-26-075705 |
| Document: 0001104659-26-075705.txt | 0001104659-26-075705 |
Track record
7 reports on GRFS
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 2, 202614d ago 6-K Neutral 2/10 Entry $8.51 to $8.69 Now $8.73 +2.59% ▲ +2.12% +2.04% vs SPY
- Nov 2, 202614d ago 6-K Bullish 6/10 Entry $8.51 to $8.69 Now $8.73 +2.59% ▲ +2.12% +2.04% vs SPY
- Aug 10, 202614w ago Press Release Neutral 4/10 Entry $8.05 to $7.77 Now $8.73 +8.45% ▼ −3.48% −3.43% vs SPY
- Jul 30, 202615w ago 6-K Neutral 2/10 Entry $8.20 to $7.83 Now $8.73 +6.46% ▼ −4.51% −8.13% vs SPY
- Jul 16, 202617w ago Press Release Neutral 4/10 Entry $7.33 to $7.54 Now $8.73 +19.10% ▲ +2.86% +4.54% vs SPY
- Jun 18, 202621w ago 6-K Neutral 3/10 Viewing Entry $7.28 to $7.39 Now $8.73 +19.92% ▲ +1.51% +3.58% vs SPY
- Mar 17, 202634w ago Press Release Bullish 7/10 Entry $8.02 to $7.60 Now $8.73 +8.85% ▼ −5.24% −2.58% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers